Inflammation MarkersEvidence & Dosage

Top studies on Inflammation Markers

Ranked by influential-citation count (Semantic Scholar) and publication year.

1. 01

   Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.

   Neurobiology of Aging·2017·n=4044 influential citations

   The pathway leading from amyloid-β deposition to cognitive impairment is believed to be a cornerstone of the pathogenesis of Alzheimer's disease (AD). However, what drives amyloid buildup in sporadic nongenetic cases of AD is still…

2. 02

   Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis

   Frontiers in Immunology·202112 influential citations

   Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both the medical and scientific community for the development of novel vaccines and a greater understanding of the effects of the SARS-CoV-2 virus. COVID-19…

3. 03

   Systemic inflammation markers and cancer incidence in the UK Biobank

   European Journal of Epidemiology·20219 influential citations

   Systemic inflammation markers have been linked to increased cancer risk and mortality in a number of studies. However, few studies have estimated pre-diagnostic associations of systemic inflammation markers and cancer risk. Such markers…

4. 04

   The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital

   European Journal of Pediatrics·2021·n=196 influential citations

   Vitamin D has an immunomodulating property that regulates the inflammatory response. In this study, the aim was to evaluate the relationship between vitamin D levels and clinical severity and inflammation markers in children and…

5. 05

   Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index

   European Journal of Applied Physiology·20215 influential citations

   Over the last decades the cellular immune inflammation markers neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII = NLR × platelets) have emerged in clinical context as…

6. 06

   Systemic inflammation markers and the prevalence of hypertension: A NHANES cross-sectional study

   Hypertension Research·2023·n=22,2905 influential citations

   Systemic inflammation markers have been highlighted recently as related to cardiac and non-cardiac disorders. However, few studies have estimated pre-diagnostic associations between these markers and hypertension. In the National Health…

7. 07

   Review on Inflammation Markers in Chronic Kidney Disease

   Biomedicines·20214 influential citations

   Chronic kidney disease (CKD) is one of the major health problems of the modern age. It represents an important public health challenge with an ever-lasting rising prevalence, which reached almost 700 million by the year 2017. Therefore, it…

8. 08

   Influence of Plant and Animal Proteins on Inflammation Markers among Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

   Nutrients·20212 influential citations

   Proteins, especially plant proteins, may reduce inflammation among adults with chronic kidney disease (CKD). This systematic review and meta-analysis were conducted to evaluate the effect protein types (animal or plant) have on…

9. 09

   Inflammation markers and the risk of hypertension in people living with HIV

   Frontiers in Immunology·20232 influential citations

   Background The incidence of hypertension is high in people living with HIV (PLWH). High-sensitivity C-reactive protein (hsCRP), systemic inflammation response index (SIRI), and neutrophil-to-monocyte ratio (NMR) are considered economic and…

10. 10

    Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial.

    Brain, behavior, and immunity·20231 influential citations

    BACKGROUND Clinical trials of anti-inflammatories in schizophrenia do not show clear and replicable benefits, possibly because patients were not recruited based on elevated inflammation status. Interleukin 1-beta (IL-1β) mRNA and protein…